Barbet J - Search Results

1

Targeting of indium 111-labeled bivalent hapten to human melanoma mediated by bispecific monoclonal antibody conjugates: imaging of tumors hosted in nude mice.

Le Doussal JM, Gruaz-Guyon A, Martin M, Gautherot E, Delaage M, Barbet J. Le Doussal JM, et al. Among authors: barbet j. Cancer Res. 1990 Jun 1;50(11):3445-52. Cancer Res. 1990. PMID: 2334941

2

Bispecific monoclonal antibody-mediated targeting of an indium-111-labeled DTPA dimer to primary colorectal tumors: pharmacokinetics, biodistribution, scintigraphy and immune response.

Le Doussal JM, Chetanneau A, Gruaz-Guyon A, Martin M, Gautherot E, Lehur PA, Chatal JF, Delaage M, Barbet J. Le Doussal JM, et al. Among authors: barbet j. J Nucl Med. 1993 Oct;34(10):1662-71. J Nucl Med. 1993. PMID: 8410279 Free article.

3

Targeting medullary thyroid carcinomas with bispecific antibodies and bivalent haptens. Results and clinical perspectives.

Rouvier E, Gautherot E, Meyer P, Barbet J. Rouvier E, et al. Among authors: barbet j. Horm Res. 1997;47(4-6):163-7. doi: 10.1159/000185460. Horm Res. 1997. PMID: 9167948

4

Targeting BCL1 lymphoma with anti-idiotype antibodies: biodistribution kinetics of directly labeled antibodies and bispecific antibody-targeted bivalent haptens.

Manetti C, Rouvier E, Gautherot E, Loucif E, Barbet J, Le Doussal JM. Manetti C, et al. Among authors: barbet j. Int J Cancer. 1997 Jun 11;71(6):1000-9. doi: 10.1002/(sici)1097-0215(19970611)71:6<1000::aid-ijc16>3.0.co;2-h. Int J Cancer. 1997. PMID: 9185704

5

Therapy for colon carcinoma xenografts with bispecific antibody-targeted, iodine-131-labeled bivalent hapten.

Gautherot E, Bouhou J, Le Doussal JM, Manetti C, Martin M, Rouvier E, Barbet J. Gautherot E, et al. Among authors: barbet j. Cancer. 1997 Dec 15;80(12 Suppl):2618-23. doi: 10.1002/(sici)1097-0142(19971215)80:12+<2618::aid-cncr37>3.3.co;2-p. Cancer. 1997. PMID: 9406716

6

Delivery of therapeutic doses of radioiodine using bispecific antibody-targeted bivalent haptens.

Gautherot E, Le Doussal JM, Bouhou J, Manetti C, Martin M, Rouvier E, Barbet J. Gautherot E, et al. Among authors: barbet j. J Nucl Med. 1998 Nov;39(11):1937-43. J Nucl Med. 1998. PMID: 9829586 Free article.

7

Immunohistology of carcinoembryonic antigen (CEA)-expressing tumors grafted in nude mice after radioimmunotherapy with 131I-labeled bivalent hapten and anti-CEA x antihapten bispecific antibody.

Gautherot E, Kraeber-Bodéré F, Daniel L, Fiche M, Rouvier E, Saï-Maurel C, Thedrez P, Chatal JF, Barbet J. Gautherot E, et al. Among authors: barbet j. Clin Cancer Res. 1999 Oct;5(10 Suppl):3177s-3182s. Clin Cancer Res. 1999. PMID: 10541361

8

Pretargeted radioimmunotherapy of human colorectal xenografts with bispecific antibody and 131I-labeled bivalent hapten.

Gautherot E, Rouvier E, Daniel L, Loucif E, Bouhou J, Manetti C, Martin M, Le Doussal JM, Barbet J. Gautherot E, et al. Among authors: barbet j. J Nucl Med. 2000 Mar;41(3):480-7. J Nucl Med. 2000. PMID: 10716323 Free article.

9

Bispecific-antibody-mediated targeting of radiolabeled bivalent haptens: theoretical, experimental and clinical results.

Le Doussal JM, Barbet J, Delaage M. Le Doussal JM, et al. Among authors: barbet j. Int J Cancer Suppl. 1992;7:58-62. Int J Cancer Suppl. 1992. PMID: 1428406 Review.

10

Enhanced in vivo targeting of an asymmetric bivalent hapten to double-antigen-positive mouse B cells with monoclonal antibody conjugate cocktails.

Le Doussal JM, Gautherot E, Martin M, Barbet J, Delaage M. Le Doussal JM, et al. Among authors: barbet j. J Immunol. 1991 Jan 1;146(1):169-75. J Immunol. 1991. PMID: 1984443

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

321 results

Search Page

Filters